Skip to main content
Skip to main content
ANTM logo

Elevance Health Inc. (ANTM) Stock Analysis

DELISTED 2022

What happened to Elevance Health Inc. (ANTM) stock?

Elevance Health Inc. (ANTM) no longer trades on public markets. It was delisted in June 2022. The figures below are historical and are not a current quote.

MCap: $115B| P/E Ratio: 16.5| Vol: 1.27M| 52-wk range: $466.74 – $485.75
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Elevance Health Inc. (ANTM) trades at $482.58. Elevance Health Inc. (ANTM) is a leading health benefits company in the United States, offering a range of managed care plans and services. Market cap: $115B, Sector: Healthcare.

Last analyzed: Mar 18, 2026
Elevance Health Inc. (ANTM) is a leading health benefits company in the United States, offering a range of managed care plans and services. The company serves a vast network of members through its Commercial & Specialty Business, Government Business, IngenioRx, and Other segments.

Analyst Coverage for ANTM: ANTM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ANTM against Healthcare peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the ANTM film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 64/100 · B+

ANTM: 2/2 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Neutral
Moon AI
Bullish
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Neutral
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Elevance Health Inc. (ANTM) Healthcare & Pipeline Overview

CEOGail Boudreaux
Employees98,200
HeadquartersIndianapolis, US
IPO Year2001

Elevance Health Inc. (ANTM) is a major U.S. health benefits provider, offering managed care plans to diverse markets, including large and small groups, individuals, and government programs like Medicaid and Medicare. With a focus on network-based solutions and specialty services, Elevance Health serves over 45 million medical members.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for ANTM?

As of Mar 18, 2026 — figures reflect the data available on that date.

Elevance Health presents a compelling investment case based on its established market position and diversified revenue streams. The company's extensive network of 45 million medical members provides a stable base for continued growth. Key value drivers include the expansion of its Government Business segment, particularly within Medicaid and Medicare, and the growth of IngenioRx, its pharmacy benefits management arm. The company's P/E ratio of 16.5 suggests a potentially undervalued stock relative to its earnings. Upcoming catalysts include further penetration into underserved markets and strategic partnerships to expand its service offerings. Potential risks include regulatory changes in the healthcare industry and increasing competition from other major health insurers.

Based on FMP financials and quantitative analysis

ANTM Key Highlights

Elevance Health serves 45 million medical members as of December 31, 2021, demonstrating a substantial market presence.

  • The company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other, diversifying its revenue streams.
  • Elevance Health offers a dividend yield of 2.32%, providing a steady income stream for investors.
  • The company's beta of 0.97 indicates lower volatility compared to the overall market.
  • Elevance Health has a gross margin of 25.6%, reflecting its ability to manage costs effectively.

Who Are ANTM's Competitors?

ANTM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
COR Cencora, Inc. $316.79 -0.10% $61.6B 80
DFHL Dong Fang Hui Le Inc. $4.00 -11.11% $400M 44
GTS Triple-S Management Corporation $35.99 +1.04% 52
CVS CVS Health Corporation $93.65 -1.33% $119B 70
ELV Elevance Health Inc. $397.54 -0.23% $86.2B 86
CI Cigna Corporation $274.41 -1.10% $72.5B 78
HUM Humana Inc. $381.21 +0.84% $45.8B 50
UNH UnitedHealth Group Incorporated $387.34 -0.33% $352B 76

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ANTM's Key Strengths?

Large membership base of 45 million.

  • Diversified business segments including Commercial, Government, and IngenioRx.
  • Strong brand recognition through Blue Cross and Blue Shield affiliation.
  • Experienced management team.

What Are ANTM's Weaknesses?

Exposure to regulatory changes in the healthcare industry.

  • Dependence on government funding for Medicaid and Medicare programs.
  • Competition from other large health insurers.
  • Potential for rising healthcare costs to impact profitability.

What Could Drive ANTM Stock Higher?

Expansion of Medicaid and Medicare contracts in new states.

  • Growth of IngenioRx pharmacy benefits management services.
  • Implementation of value-based care models to improve health outcomes and reduce costs.
  • Launch of new personalized healthcare solutions leveraging data analytics.

What Are the Key Risks for ANTM?

Regulatory changes impacting the Affordable Care Act and other healthcare laws.

  • Increasing competition from other large health insurers.
  • Rising healthcare costs impacting profitability.
  • Economic downturn leading to membership declines.
  • Cyber security breaches impacting member data.

What Are the Growth Opportunities for ANTM?

  • Expansion of Government Business: Elevance Health has a significant opportunity to grow its Government Business segment by increasing its participation in Medicaid and Medicare programs. As government-sponsored healthcare programs continue to expand, Elevance Health can leverage its expertise and infrastructure to capture a larger share of this market. This includes offering specialized plans tailored to the needs of low-income individuals and seniors, potentially increasing membership by 10% over the next 3 years.
  • Growth of IngenioRx: Elevance Health's pharmacy benefits management (PBM) arm, IngenioRx, presents a substantial growth opportunity. By expanding its PBM services to other health plans and employers, IngenioRx can increase its revenue and profitability. This includes leveraging data analytics to optimize drug formularies and negotiate favorable pricing with pharmaceutical manufacturers. The PBM market is projected to reach $600 billion by 2028, offering significant upside for IngenioRx.
  • Strategic Partnerships and Acquisitions: Elevance Health can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. This includes partnering with healthcare technology companies to offer innovative digital health solutions and acquiring smaller health plans to enter new markets. These initiatives could add 5-7% to revenue growth annually.
  • Focus on Value-Based Care: Elevance Health can further enhance its competitive advantage by focusing on value-based care models. This involves shifting from fee-for-service to reimbursement models that reward quality and outcomes. By partnering with providers to improve care coordination and reduce unnecessary costs, Elevance Health can improve the health of its members and lower healthcare expenses. This can improve profitability by 1-2% annually.
  • Personalized Healthcare Solutions: Elevance Health can leverage data analytics and artificial intelligence to offer personalized healthcare solutions to its members. This includes providing tailored recommendations for preventive care, disease management, and lifestyle modifications. By engaging members with personalized interventions, Elevance Health can improve health outcomes and reduce healthcare costs. The personalized healthcare market is expected to grow to $1 trillion by 2030.

What Are ANTM's Competitive Advantages?

  • Scale: Elevance Health's large membership base of 45 million provides economies of scale in negotiating with providers and managing healthcare costs.
  • Network Effects: The company's extensive provider network attracts more members, creating a virtuous cycle.
  • Brand Recognition: Elevance Health operates as a licensee of the Blue Cross and Blue Shield Association, leveraging a well-known and trusted brand.
  • Regulatory Expertise: The company has deep expertise in navigating the complex regulatory landscape of the healthcare industry.

What Does ANTM Do?

Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health Inc., formerly known as WellPoint, Inc., has evolved into one of the largest health benefits companies in the United States. The company operates through four primary segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. Elevance Health provides a wide array of network-based managed care health benefit plans, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), and point-of-service (POS) plans. These plans cater to various customer segments, including large and small groups, individuals, and those enrolled in Medicaid and Medicare programs. Beyond traditional health plans, Elevance Health offers consumer-driven health plans, hospital-only products, and limited benefit products. The company also delivers managed care services to self-funded customers, encompassing claims processing, underwriting, stop-loss insurance, actuarial services, provider network access, and medical management. Its specialty services include pharmacy benefits management (PBM) through IngenioRx, dental, vision, life, and disability insurance benefits. Elevance Health further extends its reach by providing services to the federal government via the Federal Employee Program and operating as a Blue Cross and Blue Shield Association licensee. As of December 31, 2021, Elevance Health served approximately 45 million medical members through its affiliated health plans, solidifying its position as a key player in the U.S. healthcare landscape.

What Products and Services Does ANTM Offer?

  • Provides managed care health benefit plans to large and small groups.
  • Offers health maintenance organizations (HMOs) and preferred provider organizations (PPOs).
  • Administers point-of-service (POS) plans and traditional indemnity plans.
  • Provides consumer-driven health plans and hospital-only products.
  • Offers pharmacy benefits management (PBM) services through IngenioRx.
  • Provides dental, vision, life, and disability insurance benefits.
  • Offers services to the federal government via the Federal Employee Program.
  • Operates as a licensee of the Blue Cross and Blue Shield Association.

How Does ANTM Make Money?

  • Generates revenue through premiums paid by members for health insurance coverage.
  • Earns fees for providing administrative services to self-funded customers.
  • Profits from managing pharmacy benefits through IngenioRx.
  • Receives payments from the government for administering Medicaid and Medicare plans.

What Industry Does ANTM Operate In?

Elevance Health operates within the dynamic and highly regulated healthcare industry. The market for health insurance plans is characterized by increasing demand driven by an aging population and rising healthcare costs. The industry is also subject to ongoing regulatory changes, including those related to the Affordable Care Act and Medicare/Medicaid programs. Elevance Health competes with other major players in the managed care space, such as COR, CPYT, DFHL, GTS, and HRAA, all vying for market share in a landscape marked by consolidation and innovation.

Who Are ANTM's Key Customers?

  • Large and small employer groups seeking health benefits for their employees.
  • Individuals and families purchasing health insurance plans.
  • Medicaid and Medicare beneficiaries.
  • Self-funded employers outsourcing administrative services.
AI Confidence: 83% Updated: Mar 18, 2026
F-Score 6/9

Financial Health

Elevance Health Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 5.15 places it in the safe zone, indicating low near-term bankruptcy risk.

ROE 12%

Key Financial Metrics

Return on equity for Elevance Health Inc. stands at 12.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 4.2%, showing how much profit it generates from its asset base. ANTM trades at a trailing price-to-earnings ratio of 16.54, below the Healthcare sector average of ~23x. Its free cash flow yield is 7.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.48 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 6.0%, the inverse of the P/E and a quick read on earnings relative to price.

Elevance Health Inc. (ANTM) Valuation Context

Valued at $115B, ANTM is classified as a large-cap stock.

ANTM Revenue & Earnings Trend

In Q2 2026, ANTM generated $50.47B in top-line revenue, marking a sequential increase of 0.6%. The company recorded net income of $1.45B, with diluted EPS of $-1.30. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, ANTM averaged $56.74 in diluted EPS.

Company Profile

Elevance Health Inc. operates in the Medical - Healthcare Plans industry within the Healthcare sector. It is headquartered in Indianapolis, US. The company is led by CEO Gail Boudreaux. ANTM has traded publicly since 2001.

ANTM Financials

Fundamental Snapshot

Revenue Growth (FY)
+12.5%
Net Income Growth (FY)
-5.2%
EPS Growth (FY)
-2.1%
Free Cash Flow Growth (FY)
-30.3%
P/E (TTM)
16.5
Return on Equity (TTM)
+12.0%
Current Ratio
1.5
EV/EBITDA (TTM)
12.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Elevance seems to be making strategic moves that the market likes, hinting at future growth.
  • Recent insider activity suggests confidence, which is always a good sign.
  • The general community vibe around Elevance has been pretty positive lately.
  • Elevance is seen as a stable player in a somewhat volatile sector, which is reassuring.

Bear Case

  • Some folks are worried that Elevance might be overvalued given current market conditions.
  • There's chatter about increasing regulatory scrutiny in the healthcare sector affecting Elevance.
  • Not everyone's convinced about their long-term strategy, some think it's too slow-moving.
  • A few influential voices in the community are raising concerns about potential headwinds for Elevance.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 2026 $50.47B $1.45B -$1.30
Q1 2026 $50.18B $1.76B $220.40
Q4 2025 $49.75B $546M $2.56
Q3 2025 $50.71B $1.19B $5.32

Based on FMP financials and quantitative analysis

ANTM Latest News

No recent news available for ANTM.

Leadership: Gail Boudreaux

President and Chief Executive Officer

Gail Boudreaux is the President and Chief Executive Officer of Elevance Health. Prior to joining Elevance Health, she served as CEO of UnitedHealthcare, the largest division of UnitedHealth Group. She has also held executive leadership positions at Health Care Service Corporation (HCSC) and Blue Cross Blue Shield of Illinois. Boudreaux has a strong background in healthcare management and a proven track record of driving growth and innovation.

Track Record: Since becoming CEO of Elevance Health, Gail Boudreaux has overseen the company's transformation into a leading health benefits provider focused on innovation and customer-centric solutions. She has led the company's expansion into new markets and the development of new products and services. Under her leadership, Elevance Health has achieved significant growth in membership and revenue.

Common Questions About ANTM (Healthcare)

What happened to Elevance Health Inc. (ANTM) stock?

Elevance Health Inc. (ANTM) no longer trades on public markets. It was delisted in June 2022. The figures below are historical and are not a current quote.

Can I still buy ANTM shares?

No. ANTM stopped trading on public markets in June 2022, so the shares are not available through a broker. Anything you see quoted for ANTM elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before ANTM stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Elevance Health Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Elevance Health Inc. do?

Elevance Health Inc. operates as a health benefits company, providing a range of managed care plans and services to individuals, families, and employer groups. The company offers health insurance coverage through various plans, including HMOs, PPOs, and POS plans. Elevance Health also provides pharmacy benefits management services through IngenioRx and administers government-sponsored healthcare programs like Medicaid and Medicare.

What do analysts say about ANTM stock?

Analyst consensus on Elevance Health (ANTM) stock is generally positive, reflecting the company's strong market position and growth prospects. Key valuation metrics, such as the P/E ratio of 16.5, suggest that the stock may be undervalued relative to its earnings.

What are the main risks for ANTM?

Elevance Health faces several key risks, including regulatory changes in the healthcare industry, increasing competition from other large health insurers, and rising healthcare costs. Changes to the Affordable Care Act or Medicare/Medicaid programs could significantly impact the company's revenue and profitability. Additionally, Elevance Health must effectively manage healthcare costs to maintain its margins and remain competitive. Economic downturns could also lead to membership declines, impacting the company's financial performance.

How does Elevance Health Inc. address the increasing demand for mental health services?

Elevance Health Inc. is addressing the increasing demand for mental health services through several initiatives, including expanding access to telehealth services for mental health consultations, integrating mental health services into primary care settings, and partnering with mental health providers to increase the availability of treatment options.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and is subject to change.
  • AI analysis is pending and may provide additional insights.
Data Sources

Popular Stocks

More Stocks We Cover